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Membrane receptors for C3b are present on a  variety of  ceils, including erythro- 
cytes,  polymorphonuclear  leukocytes,  macrophages,  and  bone  marrow-derived  (B) 
lymphocytes (1). Upon enzymatic cleavage of C3 into the fragments C3a and C3b, 
two binding sites become exposed on the C3b molecule. One binding site is short-lived 
and allows attachment of C3b to a receptor site on the cell membrane other than  the 
C3b receptor (2). The other binding site is stable and interacts with the C3b receptor 
(immune adherence receptor) (3, 4). C3b's property of binding in two different ways 
on cell membranes enables the molecule to mediate cell to cell contact, which can be 
demonstrated by techniques such as immune adherence and rosette formation between 
EAC1423 and C3b receptor-bearing cells. 
Occupation of the C3b receptor by C3b may in many instances induce changes in 
the  activity of  the  receptor bearing cells. An  example of  this  phenomenon  is  the 
phagocytosis  of  EAC1423  by  human  monocytes  after  contact  through  C3b  (5). 
Similarly, in  other  experiments  it was  shown  that  the  same monocytes  exerted  a 
cytolytic effect on chicken EAC1423 (6). These effects appeared to be triggered solely 
by C3b  since the phagocytosis or cytolysis did not require  additional complement 
components. 
C3b is a factor in the alternate pathway of complement. Together with C3PA con- 
vertase (C3PAse)  ~ it cleaves C3 proactivator (C3PA) which in turn triggers cleavage 
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of C3 into the fragments  C3a and  C3b  (7,  8). It is conceivable that receptor-bound 
C3b may initiate complement activation at the membrane.  Attachment of additional 
components may result in changes of cell activity or even cell death. 
The present  study concerns itself with the characterization  of a  C3 receptor 
on  the  Raji  line  of  lymphocytes  derived from  a  Burkitt  lymphoma.  The  re- 
ceptor binds soluble C3 as well as C3b. Lysis of cultured Raji cells occurs when 
C3b is attached  to the receptor in the presence of fresh serum. The lytic effect 
is abolished by inactivating serum C3PA and requires C6. 
Materials and Methods 
Lymphoblastoid Cell Lines.--The four cell lines used in this study were originally provided 
by Dr. R. Lerner. The Raji and  Daudi cell lines were derived from patients with Burkitt 
lymphoma (9,  10). 8866 cells were derived from the peripheral blood of a patient with acute 
myelocytic leukemia (11), and WiL2WT cells were cultured from the spleen of a patient with 
hereditary spherocyfic anemia  (12). Suspension cultures of these cell lines were propagated 
in Eagle's minimal essential medium  (MEM; Autopow, Flow Laboratories, Inc., Rockville, 
Md.)  supplemented  with glutamine, nonessential amino acids,  pyruvate,  10%  fetal bovine 
serum, penicillin, streptomycin, and Fungizone as described by Lerner et al. (13). Cell viabil- 
ity was determined by trypan blue exclusion. 
Peripheral Blood Lymphocfles.--Peripheral blood lymphocytes were obtained from normal 
healthy adults. Venous blood was defibrinated by agitation with sterile glass beads. Erythro- 
cytes were sedimented by incubating two volumes of blood with one volume of 3% dextran 
(Pharmacia Fine Chemicals, Inc., Uppsala, Sweden)  in MEM for 30 rain at 37°C. The leuko- 
cyte-rich supernatant was layered on an Isopaque-Ficoll gradient and centrifuged for 10 rain 
at  1,500 g  (14).  The layer aspirated  from the interface was washed  three  times in MEM, 
and  the macrophages were removed by using columns packed  with ny]on fibers  (15). The 
remaining preparation contained 90-95% lymphocytes. 
C3 and C3 Fragments.--C3 was prepared from human serum according to the method de- 
scribed by Nilsson and Miiller-Eberhard (16). The fragments C3b and C3c were prepared by 
enzymatic cleavage of C3 with trypsin (17). They were isolated by column chromatography and 
pevikon electrophoresis.  C3  and  the fragments were freed  of aggregates and  possible  con- 
tamination with aggregated endotoxin by centrifugation for 1 h at 100,000 g. The upper two- 
thirds of the contents of the centrifuge tubes were filtered through a 0.65 #  Millipore filter 
and stored in PBS at 4°C. 
The addition of C3b to whole serum resulted in cleavage of C3PA. The C3PA cleaving 
activity of C3b was  determined by immunoelectrophoresis.  In a  typical experiment  10-25 
/zg of C3b were added to 100 #1 of fresh human serum and incubated for 30 min at 37°C. The 
reaction mixture was subjected to immunoelectrophoresis and developed with a rabbit anti- 
human C3PA serum (7). 
Radioidination.--C3,  C3b,  and  C3c were labeled with  125I according to  the method  of 
McConahey and Dixon (18). After labeling, each preparation was dialyzed against phosphate- 
buffered saline (PBS) and then centrifuged for 90 rain at  100,000 g in order to remove any 
aggregates. No conversion of C3 was detected after labeling. The specific activity of the prepa- 
rations used was approximately 2 X  l0 s cpm//Jg protein. 
Cobra Venom Factor.--Cobra venom factor (CoF), a gift from Dr. O. GStze, was purified 
from the venom of Naja naja (Miami Serpentarium, Miami, Flor.) according to the method 
of Miiller-Eberhard and  FjellstrSm  (19). The isolated material was centrifuged for  1 h  at 
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thirds of the contents of the centrifuge tubes was filtered through a 0.65/~  Millipore filter and 
stored in PBS at --70°C. 
Antisera.--Antihuman  C3  sera were prepared by immunizing rabbits with isolated  C3 
(17). The anti-C3 sera used in this study reacted with C3 and the fragments C3b,  C3c, and 
C3d when tested by double diffusion in agar. The anti-C3 serum gave a single precipitin line 
when tested against normal human serum  (NHS)  or isolated C3  on  Ouchterlony analysis 
and immunoelectrophoresis. The anti-C3 serum agglutinated EAC'1423 up to a  1:256  dilu- 
tion. Anti-C3a was produced by immunizing rabbits with isolated C3a  (17). The anti-C3a 
serum formed a precipitin line with C3a as well as C3 in agar double diffusion.  No reaction 
was observed with C3b.  Antirabbit IgG sera were produced by immunization of goats with 
isolated rabbit IgG. 
Immunofluorescent Staining.--Antisera were conjugated according to  described methods 
(20).  C3  and C3b bound to cell  surface were detected by immunofluorescent staining with 
fluorescein isothiocyanate (FITC)-conjugated rabbit antiC3.  In a  typical experiment 5 X 
106 cells in 25 #1 of MEM were incubated under gentle shaking with the various amounts of 
C3, C3b, aged human serum, or NHS at 37°C for  30 rain. Aged human serum used in this study 
contained the fragments C3c and C3d but not C3  and C3b as demonstrated by immunoelec- 
trophoretic analysis using a potent anti-C3 serum (17, 21).  Subsequently, cells were washed 
three times with MEM and 25 #1 of FITC anti-C3 was added. The mixture was incubated 
with genre shaking for 30 rain at 4°C.  The ceils were then washed three times with MEM 
and resuspended in 10 #1 of 10% bovine serum albumin (BSA) in PBS. Cell smears were air 
dried, fixed in 95% cold ethanol, and mounted under glycerogel. Wet preparations were made 
by sealing a  drop of the cell solution with paramount under a  cover slip. Smears were ob- 
served by using a Zeiss RA microscope (Carl Zeiss, Inc., New York) equipped with the FITC 
interference filter system (Optisk Laboratorium, Lyngly, Denmark)  and illuminated from a 
HBO 200 watt mercury light source. 
To demonstrate native C3 on cell surfaces, an indirect staining technique was used. 5 X  106 
C3 or C3b beating cells were allowed to react with rabbit anti C3a. The washed cells were sub- 
sequently stained with flnorescein-conjugated  goat antirabbit IgG. 
Erythrocyte-Antibody-Complement Complexes (EAC).--EAC1423  cells were prepared with 
purified human  complement components. Purified macromolecular CI  was prepared from 
human serum according to Nelson et al.  (22).  C2 was purified as described previously (23) 
and was used exclusively in its oxidized form (24) unless otherwise stated. C4  (25) and C3 
(16)  were obtained according to published methods. 5 X  109 sheep erythrocytes (E)  sensi- 
tized with rabbit antierythrocyte antibody (A) were incubated with purified C1 for 20 min 
at 37°C,  washed with GVB  (5ram veronal buffered saline with 1.0% gelatin, 1.5 X  10  -4 M 
calcium, and 5 X  10  -4 M  magnesium) and then reacted with 100 #g of purified C4 for 30 
min at 37°C.  Subsequently, the EAC14 ceils were washed with GVB and reacted again with 
C1 for 15 rain at 37°C.  After additional washing with GVB an excess amount of oxyC2  was 
added and the cells were incubated for 30 rain at 32°C. Mter three washes in 0.01 M  EDTA 
containing GVB,  1 X  109  EAC14oxy2 ceils were incubated with  100/zg  purified C3 for 20 
rain  at  30°C.  Thereafter,  the EAC14oxy-~ ceils were washed  three  times with  GVB  and 
stored  at  4°C  at  a  final  concentration of  1 X  109 cells/ml. EAC1423  were made as with 
EAC~ but C2 was used in its nonoxidized  form. One batch of cells could be used over 
a  period of seven days. 
Rosette Formation of C3  Receptor-Bearing Cells with  EAC14oxy23.--2 X  106  lymphoid 
cells were incubated with 5 X  107 EAC1--~xxy23  in a total volume of 200/zl of MEM at 37°C 
for 30  rain during which time the mixture was shaken twice by hand. Thereafter, the cells 
were suspended in 1 ml MEM and placed on ice for 10 rain. Rosetted (four or more bound 
EAC14oxy23)  and unrosetted lymphocytes were counted in a  hemocytometer using a  Zeiss 
phase contrast microscope (Carl Zeiss, Inc.). 500 cells were counted and theper cent of rosette- 
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Immune Adh~ence.--Immune adherence experiments were performed in microtiter plates 
(Cook Engineering Co., Alexandria, Va.). In a  typical experiment each well was filled with 
25/~l of veronal buffer pH 7.5, T/2 0.1  containing 0.1% human serum albumin. 25/~l of 1 X 
109 Raji cells, which had been preincubated with C3b, were placed into the first well and dilu- 
tions were made using a 25/~l microtiter loop. Mter addition of 25/~l of a human O group red 
cell suspension containing 2 X  10 s red cells per ml to all wells, the plates were agitated for 
5 rnin and then incubated for 30 min at 37°C after which time the sedimentation pattern was 
evaluated. Dilutions of EAC14oxy23 were used as positive controls. 
RESULTS 
Binding of C3 and C3b in Free Solution  to Receptors on Raft Cells.--When 
5 X  106 Raji cells were incubated for 30 min at 37°C in MEM containing 10 ~l 
of fresh human serum nearly 100 % of the cells were positive when subsequently 
stained with FITC anti C3 (Fig. 1). In contrast, incubation with even ten times 
as much aged human serum gave no positive cells. Human serum treated with 
CoF, resulting in cleavage of C3 into C3a and C3b, (26)  gave a staining (not 
shown) similar to that of fresh human serum. These results indicate that  C3 
and C3b bind to receptor sites on Raji cells. In contrast, it was shown that C3c 
and C3d which are present in aged human serum did not bind to the cells. 
A possible mediation of the binding of C3 and C3b to Raji cell receptors by 
other complement or serum factors was excluded, since incubation with isolated 
C3 and C3b at concentrations equivalent to that of serum resulted in nearly 
100 % staining of the cells (Fig. 1).  Binding of C3 and C3b proceeds in the pres- 
ence of 0.01 M EDTA. 
Binding of C3 and C3b to Raji cells is to some extent temperature dependent. 
When incubation with  C3  and C3b was carried out at 4°C,  only 40% were 
fluorescence positive as compared to nearly 100%  after  incubation at 37°C. 
The pattern of staining also varied with temperature  (Fig.  2).  Incubation of 
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FIG.  1.  Demonstration of Raji cell-bound C3  and C3b by immunofluorescence. 5 >(  106 
Raji cells were incubated with various amounts of NHS (e--Q),  C3  ~i--i),  C3b (A--A) 
and aged human serum containing C3c and C3d (©--©). C3 and C3b were at concentrations 
of 1.5 rag/m1. Cells were stained with FITC antihuman C3. 700  RECEPTOR  FOR  SOLUBLE  C3  AND  c3b  ON  RAJI  CELLS 
FIG.  2.  Immunofluorescent staining patterns  of  C3-bearing Raji cells.  (a)  Incubation of 
cells with C3 and staining with FITC anti-C3 were carried out at 4°C.  (b) Incubation at 37°C 
and staining at 4°C.  (c) Incubation and staining at 37°C. 
Raji cells with C3 or C3b at 4°C resulted in fine granular staining  (Fig.  2 a) 
whereas incubation at 37°C produced coarse spots in often polar distribution 
(Fig.  2  b).  In  these experiments fluorescent staining was carried out at  4°C. 
When incubating with  C3  or C3b and staining was carried out at 37°C,  cap 
formation was observed in some cells (Fig. 2 c). 
Physicochemical State of Bound C3.--In the  preceding section it was  shown 
that binding of C3  and C3b was not mediated by additional complement or 
serum  factors.  It  is  conceivable that  cell  membrane-bound  enzymes might 
cleave C3 before attachment, in this case only the C3b portion of the molecule 
would bind to the receptor. Antiserum to the C3a fragment and the fluorescent 
sandwich  technique  were  employed  to  study  the  physicochemical  state  of 
receptor-bound C3. The results of these experiments are summarized in Table 
I. 100 % of the Raji cells incubated with 50 ~g C3 reacted with anti C3a anti- 
serum, whereas only 5 % of cells incubated with 50 #g C3b reacted with this 
antiserum, indicating that C3 was bound to Raji cells in its native form. 
C3 and C3b-bearing Raji cells gave no immune adherence pattern when tested 
at various concentrations with human erythrocytes. This suggests that binding 
of C3b occurs through the immune adherence region of the molecule and not the 
C3d portion. A.  N.  THEOFILOPOULOS,  V.  A.  BOKISCH,  AND  F.  J.  DIXON 
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Incubation  Staining procedure  Positive cells 
Raji +  medium  Rab anti-C3a 
Raji +  C3  Rab anti-C3a 
Raji+  C3b  Rab anti-C3a 
Raji +  C3  NRS 
% 
FITC sheep anti-Rab IgG  0 
FITC sheep anti-Rab IgG  100 
FITC sheep anti-Rab IgG  5 
FITC sheep anti-Rab IgG  0 
Comparison  of the Binding of Soluble C3 and C3b and of RBC Bound C3b to 
Lymphocyte Membrane C3 Receptors.--The ability of four different cell lines and 
of peripheral lymphocytes to bind C3 and C3b in free solution was compared to 
their  ability to  form rosettes with  EAC14oxy23  cells.  Binding  of  soluble  C3 
and  C3b  was  determined  by  immunofluorescence  as  described  above.  The 
results of these experiments are summarized in Table II. Within each cell type, 
roughly the same percentage of cells bound  soluble C3b  and formed rosettes 
with EAC14oxy23 100% of Raji cells were positive in both tests, whereas only 
5%  of  the  other  three  lines  were positive.  In  contrast  to  peripheral  blood 
lymphocytes, all four cell lines also  bind soluble C3 to almost the same extent 
as C3b. 
Specificity of the C3 Receptor on Raft Cells.--While it was not possible to show 
directly that both C3 and C3b bound to the same receptor site, it was possible 
indirectly to demonstrate that they bound to the same or closely associated sites 
by inhibition of Raji cells-EAC14oxy23 rosette formation. Fig. 3 shows that in- 
cubation of Raji cells with increasing amounts of C3 or C3b and subsequent 
suspension in MEM  before addition  of EAC14oxy23  inhibited  rosette forma- 
tion. However, it had to be considered that red cell-bound C4oxy2 enzyme with 
a half life at 37°C of 150-200 min (27) could cleave Raji cell-bound C3 into C3a 
and C3b. Thus, inhibition of Raji-EAC14oxy23 rosette formation could be due 
to C3b rather than C3. To exclude this possibility EAC1423 were prepared with 
nonoxidized C2, which forms a  C42 enzyme with a half life at 37°C of only 10 
min  (27). When EAC1423 previously decayed to EAC143  were used,  C3 and 
C3b inhibited rosettes to the same extent as with EAC14oxy23 cells.  Rosettes 
could  also be completely inhibited  by preincubation  of Raji  cells with  fresh 
NHS. In contrast, aged human serum which contained the fragments C3c and 
C3d did not significantly inhibit rosettes (Fig. 3). Rosettes between Raji cells 
and EAC1423  could also be dissociated by C3 or C3b. In both inhibition and 
dissociation of rosettes,  C3  was more effective than  C3b when used at equal 
concentrations. 
Quantitation  of C3 and  C3 Fragments Bound  to Raji Cell Membrane.--The 
number of molecules of C3, C3b, and C3c which were bound per Raji cell was 
determined by uptake experiments. 2.5  X  10  ~ cells were incubated with increas- 
ing  amounts of radiolabeled  C3,  C3b,  or C3c  in  a  total volume of 250/~1  of 702  RECEPTOR  FOR  SOLUBLE  C3  AND  C3b  ON  RAJI  CELLS 
TABLE II 
Comparison of the Binding  of Soluble C3 and  C3b and  of RBC-Bound  C3b to Lymphocyte 
Membrane C3 Receptors 
Percent cells binding*  Cell type  Ce]ls forming 
C3  C3b  rosettes with EAC1423 
%  % 
Raji  100  100  95-100 
Wil~WT  5  2-3  2-3 
8866  5  5  5 
Daudi  20  5  2-3 
Peripheral lymphoeytes~  0  20  20 
* The binding of soluble C3 and C3b was assessed by staining with FITC antihuman C3. 
Average of ten experiments. 
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FIG. 3. Inhibition  of Raji cell-EAC1423 rosette formation  by NHS,  C3,  C3b, and  aged 
human serum (C3c and C3d). 
0.1% human serum albumin in MEM. The binding curves of the different pro- 
teins are depicted in Fig. 4. Addition to Raft cells of 250/A of MEM containing 
20 pg C3,  an  amount  corresponding  approximately  to  one-twentieth  of  the 
serum C3 concentration, occupied 80 %  of the available C3 receptors  (Fig. 4). 
At saturation,  approximately 4  X  105 molecules of C3 were bound per  Raji 
cell. The receptor  on Raji cells  has a greater binding affinity for C3 than C3b 
prepared with trypsin; almost two times more C3b than C3 had to be  offered 
to  the  cells  in  order  to  bind  the  same  number  of molecules.  Uptake  of C3c 
molecules was approximately one-seventh that of C3 and C3b. 
Effect of C3b Inactivator on Raji Cell-EA C14oxy23 Rosette Formation.--Bind- 
ing of soluble C3c and C3d present in an aged human serum on Raji cells could 
not be detected by the immunofluorescence method. However, since a receptor 
for  red  cell-bound  C3d  has  been  recently  reported  to  be  present  on  human 
lymphocytes (28),  experiments  were performed in order  to explore  the possi- 
bility of red cell-bound C3d binding to Raji cells. Since C3b inactivator (C3bina) A.  N.  THEOFILOPOULOS~  V.  A.  BOKISCH,  AND  P.  J.  DIXON  703 
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FIG. 4. Uptake of 125I-labeled C3, C3b, and C3c by Raji cells. 
can  cleave  C3b  to  C3c  and  C3d  (29)  and  treatment  of  EAC14oxy23 with 
C3bina results in release  of C3c and retention of C3d on the red cell  surface 
(29),  the  following experiments  were  performed:  (a)  5  X  l0  T EAC14oxT~, 
preincubated for 90 min at 37°C with a sufficient amount of C3bina  2 to render 
them immune adherence negative, were incubated with Raji cells and the num- 
ber of rosettes was counted. It was found that Raji cells continue to form ro- 
settes  with  such  erythrocytes in  a  percentage similar  to  that  obtained with 
EAC14oxy23 not  treated  with  C3bina.  (b)  A  similar  amount of C3bina was 
added  to  preformed  Raji  cell-EAC14oxy23 rosettes;  after  incubation  for  90 
rain at 37°C no dissociation of rosettes was seen.  (c) C3bina mixed with EAC- 
14oxy23 cells  was  added  to  Raji  cells;  after  incubation  for 90 min  at  37°C 
no inhibition of rosette formation was seen. 
Effect of Trypsin on the C3 Receptor.--Raji cells incubated in a 0.01% trypsin 
solution in MEM for 15 min at 37°C were no longer capable of binding soluble 
C3 and C3b or of forming rosettes with EAC14oxy23. 
Effect  of Complement Activation  by CoF on Cell  Viability.--Since  C3b  acti- 
vates  the  alternate  pathway of complement  (7),  receptor-bound  C3b  might 
cause  lysis  of  C3  receptor-bearing  cells  through  complement  activation.  To 
check the susceptibility of Raji cells to lysis by the alternate complement path- 
way, complement was activated  by CoF (26)  in cultures.  Raji cells  were sus- 
pended at a concentration of 2 X  105 cells/ml in medium containing 10 % fresh 
or heat-inactivated human serum (50°C,  20 rain). Viable cells were counted at 
different time intervals and the number was expressed as the percentage of the 
number at 0 time. Addition of 200 gg CoF to 20 ml of cell culture containing 
fresh human serum resulted in loss of 75 % of cells in 24 h  and 100 % in 48 h 
(Fig.  5 A).  Cells  removed from culture  two hours after the addition of CoF 
2 C3b inactivator used in this study was a gift from Dr. Nell Cooper.  The activity of C3bina 
was assessed by its ability to render EAC~  cells negative in immune adherence tests 
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FIG.  5.  (A)  Effect  of complement  activation  by  CoF  on  Raji cells  in culture.  2  X  105 
cells/ml were cultured in medium containing fresh human serum (©--©)  or in medium con- 
taining CoF-treated fresh (O--O)  and heat-lnactivated (50°C, 20 rain)  human serum(ZX--ZX). 
(B)  Effect of complement  activation  by CoF  on 8866 and  Daudi  cells in culture.  2  X  105 
cells/ml of each cell line were cultured in medium containing fresh human serum (open signs) 
or medium containing CoF-treated fresh human serum (closed signs). 
lacked the C3a determinant on their surface. CoF had no effect on Raji cells 
cultured in medium containing heat-inactivated human serum. In contrast to 
Raji cells,  CoF had no effect on 8866 and Daudi cells cultured in medium con- 
taining fresh human serum (Fig. 5 B). 
Effect  of Receptor Bound C3b on Raft Cell Viability.--To  test  the  effect of 
Raji cell bound C3b on cell viability, C3b-bearing Raji cells were cultured  in 
medium  containing  fresh  or  heat-inactivated  (50°C,  20  min)  human  serum. 
In these experiments batches of 5 X  106 Raji cells were incubated for 30 rain at 
37°C in 100/~1 MEM containing 100/ag C3b or 100/~g human serum albumin. 
Incubation  in  albumin  served  as  control.  Thereafter,  the  cells  were  washed 
three times and resuspended in 20 ml of the appropriate culture medium. Fig. 
6 depicts the growth curve of C3b-bearing Raji cells cultured in medium con- 
taining  fresh  or heat-inactivated  human  serum  and  that  of albumin-treated 
Raji  cells  in  medium  containing  fresh  human  serum.  A  70%  loss  of viable 
C3b-bearing Raji cells cultured in fresh human serum was observed after 24 h. 
In contrast,  no  effect on  the  growth  of C3b-bearing cells cultured  in heated 
human serum or albumin-treated Raji cells cultured in fresh human serum was 
noted. The rapid loss of viable C3b-bearing Raji cells in the presence of fresh 
serum but not in the presence of heated serum  (50°C,  20 rain)  suggested the 
participation of C3PA in cell lysis. 
Participation  of C6 in  Raft  Cell  Lysis.--Participafion  of  C6  in  the  C3b 
initiated  lysis of Raji  cells was  studied  by culturing  C3b-bearing  Raji  cells 
(2 X  105/ml) in medium containing 10% of either C6 deficient or normal rabbit 
serum (NRS) (Fig. 7). The number of viable C3b-bearing Raji cells was drasti- 
cally reduced in the presence of NRS, whereas no reduction of cell numbers was 
observed in the presence of C6 deficient serum. Raji cells without C3b on their 
surface grew normally in either serum. Hence destruction by C3b requires C6. A.  N.  THEOFILOPOULOS~  V.  A.  BOKISCH,  AND  ]L  J.  DIXON  705 
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FIo. 6. Effect of bound C3b on Raji cells in culture. 5  X  106 C3b-beating Raji cells were 
cultured in 20 ml medium containing either fresh (Q--Q)  or heat-inactivated (50°C,20 rain) 
human serum  (O--O).  Control cells pretreated with human serum  albumin  were cultured 
in fresh human serum (A--A). 
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FIG. 7. Culture of C3b-bearing Raji cells (2 X  10 5 cells/ml) in medium containing normal 
(e--e)  or C6-defident (O--©) rabbit serum. Raji cells without surface-bound C3b were 
used as controls in normal (&--A) and C6-deficient (A--A) rabbit serum. 
DISCUSSION 
This study describes the binding properties and a biologic function of the C3 
receptor on Raji  cells. The binding of soluble C3  and C3b  to Raji  cells was 
demonstrated by the detection of these proteins on the cell surface with fluo- 
resceinated anti-C3 serum and by the inhibition or dissociation (in the presence 
of C3 and C3b) of rosettes formed between Raji cells and EAC1423. The bind- 
ing of soluble C3 and C3b was directly shown with radiolabeled proteins. Our 
experiments  with  human  peripheral  lymphocytes  also  showed  that  soluble 
C3b  can bind  to  the  C3b  receptor present  on  a  portion  of those  cells.  Such 
binding of soluble proteins to receptors for C3  or C3b  has hitherto  not been 706  RECEPTOR  FOR  SOLUBLE  C3  AND  C3b  ON  RAJI  CELLS 
observed, although Eden and associates  (4)  postulated the binding of guinea 
pig C3b to the C3 receptor of mouse B lymphocytes. They showed that guinea 
pig serum treated with EAC14---2  inhibited rosette formation between mouse B 
lymphocytes and EAC  4~2-3. In the present study it was found that there was 
no requirement for other complement proteins or serum factors to mediate the 
binding of C3  or C3b to the receptor, since the isolated proteins bind to the 
receptor. However, it also had to be investigated whether a membrane-bound 
enzyme or cellular proteases released in the medium during the time of incuba- 
tion could cleave C3 into the fragments C3b and C3a before binding to the re- 
ceptor. If this was so, it was possible, as in the case of the human peripheral 
lymphocytes, that only C3b would bind to the Raji cell receptor. The possibility 
of enzymatic cleavage of C3 by released or cell bound enzyme was, however, 
ruled out by demonstrating the presence of  antigenically  intact C3  on  Raji 
cells.  The ability to bind C3  and C3b  distinguishes the C3 receptor on Raji 
cells from the C3b receptor on human peripheral lymphocytes which only bind 
C3b. 
Inhibition and dissociation of Raji cell-EAC14oxy23 rosettes by C3 and C3b 
indicated that both molecules were binding to the same receptor or to closely 
associated receptors on the cell membrane. The possibility that C3b generated 
from Raji cell-bound C3,  by the C4oxy2 enzyme on red cells,  was responsible 
for the inhibition of Raji-EAC14oxy23 rosettes was  ruled out by the use of 
EAC1423  cells.  Rosettes of Raji cells with EAC1423  and EACl-~-~y23 were 
inhibited to the same degree by C3. 
The fact that C3b-bearing Raji cells are immune adherence negative suggests 
that  C3b  binding  to  the  C3  receptor is  brought about  through  the immune 
adherence region of the molecule and not the C3d portion. It has been previously 
shown that C3b is bound to EAC'142 cells through the C3d portion of the mole- 
cule. The C3c portion is exposed and mediates immune adherence (29). 
The receptor for C3 and C3b on Raji cells is trypsin sensitive like the C3b 
receptor on peripheral lymphocytes (1),  and binding of C3  and C3b  to Raji 
cells  is  temperature-dependent.  It  has  been  previously  shown  that  rosette 
formation between B  cells and EAC' is greatly inhibited at 4°C  (1).  It was 
demonstrated by staining of C3- or C3b-bearing cells at 4°C that the C3  re- 
ceptor on  Raji  cell  membranes  is  uniformly  distributed.  Cap  formation in 
some cells when staining was carried out at 37°C indicated that the C3 receptor 
can move in the membrane plane.  Similar patterns of staining have been ob- 
served with  B  type lymphocytes carrying Ig on their membranes  (30).  Raji 
cells used in this study were lacking membrane-associated Ig (31) and therefore 
the possibility of the receptor being some class of Ig is excluded. 
Uptake experiments showed that approximately 4  X  105 molecules of radio- 
labeled C3 or C3b bind per Raji cell. This number is 20 times larger than the 
number of membrane associated IgG molecules on other lymphoblastoid cells; 
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(31).  The  same  experiments  also  indicated  that  the  receptor has  a  higher 
affinity for C3 than C3b, since almost two times more C3b than C3 had to be 
offered to the cells in order to bind the same number of molecules. The higher 
affinity of C3 for the receptor was also shown by the fact that C3 was more 
potent than C3b in inhibiting Raji celI-EAC1423 rosette formation. 
In addition to the described C3 receptor, another receptor specific for C3b 
inactivator-cleaved C3b (C3d) bound to red cells was shown to be present on 
Raji cells. The presence of a receptor for C3d was demonstrated by the forma- 
tion of rosettes between Raji cells and EAC14oxy23 which had been previously 
treated with  C3b inactivator and were immune adherence negative. In addi- 
tion,  C3b  inactivator did not dissociate preformed rosettes  and its  presence 
did  not have  any effect on rosette formation between  Raji  cells and  EAC- 
14oxy23.  Finally,  EAC  ~ prepared  with  whole  C5-deficient mouse  serum  in 
which C3b inactivator is present continued to form rosettes with Raji cells; pre- 
incubation of Raji cells with human  or mouse serum did not inhibit rosette 
formation between Raji cells and EAC' made with C5-deficient mouse serum 
(unpublished observations). These findings are in  accordance with Ross  and 
associates, who have recently reported the presence of two different complement 
receptors on human  lymphocytes,  one specific for  C3b  and  one specific for 
C3b  inactivator-cleaved  C3b  (28).  In  contrast  with  the  rosette  formation 
between Raji cells and C3bina treated EAC14oxy23, binding of the soluble C3d 
and C3c, present in aged human serum, could not be detected by the immuno- 
fluorescence method. 
C3b together with  C3PA  and  C3PAse  activates the  alternate pathway of 
complement which in turn leads to cleavage of C3 into C3a and C3b (7). Since 
our experiments have shown that Raji cells bind a large number of C3b mole- 
cules, it is conceivable that  in the presence of whole human serum cell-bound 
C3b could activate the alternate pathway of complement and thereby lead to 
membrane  damage.  The fact  that  Raji  cells  are  susceptible to  lysis by the 
alternate  complement  pathway  was  demonstrated  in  experiments  in  which 
CoF, which activates the alternate complement pathway  (26),  was  added to 
Raji  cells cultured in medium  containing fresh human  serum.  It was  found 
that  after 24 h  of incubation 75 %  of the cells were lysed. In contrast,  8866 
and Daudi cells were not lysed under the same experimental conditions. There- 
fore, experiments were designed to assess  a possible effect of Raji cell bound 
C3b on cell viability in the presence of fresh human serum. When C3b-bearing 
cells were cultured in medium containing fresh serum, lysis of these cells ensued. 
Lysis was abolished by heat inactivation of serum C3PA (50°C,  20 min), indi- 
cating  that  activation of the  alternate  complement pathway  by  cell-bound 
C3b  was  responsible for  cell destruction.  Furthermore,  lysis  of C3b-bearing 
Raji cells in culture medium containing  normal  but  not  C6-deficient rabbit 
serum indicated the participation of C5 and C6 in this reaction. 
It is conceivable that the described mechanism of lysis of C3b-bearing cells 708  RECEPTOR  FOR  SOLUBLE  C3  AND  c3b  ON  RAJI  CELLS 
under culture conditions is also operative in vivo. C3 antigenic determinants 
have been found on Raji cells obtained directly from patients (32). Occupation 
of the C3 receptor by C3b could be achieved in two ways. Cell-bound C3 could 
either be converted to C3b on the cell surface or be replaced by C3b generated 
in plasma. In effect, our experiments with cultured Raji cells showed that C3- 
bearing cells in fresh human serum converted to C3b-bearing cells after addition 
of CoF.  Cell-bound C3b could then lead to membrane damage through com- 
plement activation. 
In this context it should also be mentioned that other cell lines exhibited 
properties similar to Raji cells as far as C3 binding is concerned. The cells from 
three  lymphoblastoid  lines,  established  by  Dr.  B.  Croker  from  peripheral 
lymphocytes of two patients with disseminated lupus erythematosus and one 
patient with  Sjtgren's syndrome, were able to bind  soluble  C3  and C3b? It 
remains  to  be  established  if in  these patients  their peripheral  lymphocytes 
themselves can bind C3. 
Although cell destruction by this mechanism may play an important role in 
controlling cell growth,  it probably constitutes only one  consequence of the 
presence of the C3 receptor on cell membranes. It is likely that in other C3 
receptor-bearing cells resistant to lysis by the alternate complement pathway, 
activation of complement on membrane surfaces may result in changes of cell 
activity instead of cell death.  In  this  connection it has been postulated,  for 
example,  that  binding of C3b  to the  C3b  receptor of B  lymphocytes  has  a 
controlling influence on  antibody production and  that  complement receptor 
plays an important role in T- and B-cell interaction (33-35). Studies are under 
way to investigate the influence on various cell activities of C3b binding to C3 
receptor-bearing cells. 
SUMMARY 
This study describes the presence of a receptor for fluid phase human C3 and 
C3b on Raji cell membranes. The binding of C3  and C3b was demonstrated 
indirectly by  a  fluoresceinated anti-C3  serum  and  directly by  using  radio- 
iodinated proteins. No other complement proteins or serum factors were needed 
to mediate binding of C3 and C3b to the receptor. The possibility of enzymatic 
cleavage of C3 before or after its attachment on the cell membrane was ruled 
out by the demonstration of antigenicaily intact C3 on Raji cells.  Inhibition 
and dissociation of Raji cell-EAC1423 rosettes by C3  and C3b indicated that 
both of these proteins bind to the same receptor site or closely associated re- 
ceptor  sites  on  Raji  cells.  C3b-bearing  Raji  cells  were  immune  adherence 
negative, indicating that C3b binding to the receptor is brought about through 
the immune adherence region of the molecule and not the C3d portion. The C3 
receptor on Raji cell membranes is uniformly distributed and can move on the 
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membrane plane.  Approximately 4  X  105  molecules of C3  or  C3b  bind per 
Raji cell. The receptor had a higher affinity for C3 than C3b, as was shown by 
uptake  experiments  and  inhibition  of  Raji  cell-EAC1423  rosette formation. 
Apart from the described receptor for C3 and C3b another specific receptor for 
C3b inactivator-cleaved C3b (C3d) bound to red cells was shown to be present 
on Raji cells. 
Raji  cells  cultured  in  medium  containing  fresh normal human  serum  and 
cobra venom factor were lysed. Similar results were obtained when C3b-bearing 
Raji cells were cultured in medium with fresh normal human serum. The lyric 
effect could be abolished by inactivating serum C3 proactivator (C3PA)  and 
required  C6.  It was  concluded  that  C3b  bound  to  the  Raji  cell  membrane 
activates the complement system through  the  alternate pathway and results 
in membrane damage and cytolysis. It is postulated  that  cell destruction by 
this mechanism may play an important role in vivo in controlling cell growth. 
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